Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > FYI

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Nov 02, 2021 4:46pm

109 Views

Post# 34079298

RE:RE:RE:FYI

More negative if she left of her own accord as that may indicate something negative regarding cancer's prospects. If she was asked to leave, that may indicate they do not think she is the person they need as they launch into something much bigger.

qwerty22 wrote:
Either way seems negative.

SPCEO1 wrote: I have been told by a none company source that her departure is official. I don't know if she left or was asked to leave.

SPCEO1 wrote: I suspect this means something, but it could just be some sort of screw up, but I have been told that Leah's phone number now gives a message that her number has been disconnected.